Rocket Pharmaceuticals, Inc. (RCKT) stock
RCKTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.11−0.05 (-2.31%)
Close on Nov 17, 2026Market cap $231.62MP/E –Yield –
Rocket Pharmaceuticals EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Rocket Pharmaceuticals's EV/EBITDA was 3.0× on Jan 31, 2018.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2018 | Jan 31, 2018 | 3.0× | – |
See a number that looks wrong?